BL802c : Bladder cancer tissue array, including clinical stage, TNM and pathology grade, 80 cases/80 cores (core size 1.5mm), replacing BL802b
|
Microarray Panel | Bladder carcinoma tissue microarray, containing 57 cases of invasive urothelial carcinoma, 2 adenocarcinoma, 1 squamous cell carcinoma, 8 normal adjacent bladder tissue, 2 cancer adjacent bladder tissue, 10 bladder tissue, single core per case | |
Cores | 80 | |
Cases | 80 | |
Row number | 8 | |
Column number | 10 | |
Core Diameter (mm) | 1.5 | |
Thickness (µm) | 5 | |
Quality Control | H&E and IHC confirmed | |
Tissue Array Type | FFPE | |
Species | Human | |
Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Legend: | Bla - Bladder
|
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Image |
---|
A1 | 1 | 69 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
A2 | 2 | 56 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
A3 | 3 | 54 | F | Bladder | Low grade invasive urothelial carcinoma | T3N0M0 | - | III | Malignant | |
A4 | 4 | 56 | F | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
A5 | 5 | 76 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
A6 | 6 | 76 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
A7 | 7 | 60 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
A8 | 8 | 37 | F | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
A9 | 9 | 38 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
A10 | 10 | 66 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
B1 | 11 | 75 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
B2 | 12 | 59 | F | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
B3 | 13 | 72 | F | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
B4 | 14 | 58 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
B5 | 15 | 57 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
B6 | 16 | 45 | F | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
B7 | 17 | 70 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
B8 | 18 | 63 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
B9 | 19 | 62 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
B10 | 20 | 40 | F | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
C1 | 21 | 49 | F | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
C2 | 22 | 65 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
C3 | 23 | 42 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
C4 | 24 | 45 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
C5 | 25 | 61 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
C6 | 26 | 72 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
C7 | 27 | 79 | F | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
C8 | 28 | 66 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
C9 | 29 | 66 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
C10 | 30 | 60 | M | Bladder | High grade invasive urothelial carcinoma (sarcomatoid type) | T2aN0M0 | - | II | Malignant | |
D1 | 31 | 71 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
D2 | 32 | 64 | F | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
D3 | 33 | 54 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
D4 | 34 | 71 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
D5 | 35 | 58 | F | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
D6 | 36 | 54 | F | Bladder | Low grade invasive urothelial carcinoma | T3aN0M0 | - | III | Malignant | |
D7 | 37 | 61 | F | Bladder | Low grade invasive urothelial carcinoma | T3aN0M0 | - | III | Malignant | |
D8 | 38 | 50 | F | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
D9 | 39 | 51 | M | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
D10 | 40 | 77 | F | Bladder | High grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
E1 | 41 | 42 | M | Bladder | Low grade invasive urothelial carcinoma with adenoid differentiation | T2aN0M0 | - | II | Malignant | |
E2 | 42 | 59 | F | Bladder | High grade invasive urothelial carcinoma with giant cell variants | T3bN0M0 | - | III | Malignant | |
E3 | 43 | 55 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
E4 | 44 | 60 | F | Bladder | Low grade invasive urothelial carcinoma (clear cell type) | T3bN0M0 | - | III | Malignant | |
E5 | 45 | 68 | M | Bladder | High grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
E6 | 46 | 74 | M | Bladder | Low grade invasive urothelial carcinomawith adenoid differentiation | T2aN0M0 | - | II | Malignant | |
E7 | 47 | 76 | F | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
E8 | 48 | 73 | F | Bladder | Low grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
E9 | 49 | 51 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
E10 | 50 | 70 | M | Bladder | Low grade invasive urothelial carcinoma | T2bN0M0 | - | II | Malignant | |
F1 | 51 | 75 | M | Bladder | Low grade invasive urothelial carcinoma | T2bN0M0 | - | II | Malignant | |
F2 | 52 | 76 | M | Bladder | High grade invasive urothelial carcinoma (rich in lipid type) | T2aN0M0 | - | II | Malignant | |
F3 | 53 | 75 | M | Bladder | High grade invasive urothelial carcinoma | T2bN0M0 | - | II | Malignant | |
F4 | 54 | 45 | M | Bladder | Low grade invasive urothelial carcinoma (clear cell type) | T3bN0M0 | - | III | Malignant | |
F5 | 55 | 74 | M | Bladder | High grade invasive urothelial carcinoma | T3N0M0 | - | III | Malignant | |
F6 | 56 | 53 | M | Bladder | High grade invasive urothelial carcinoma | T3N2M0 | - | IV | Malignant | |
F7 | 57 | 48 | M | Bladder | High grade invasive urothelial carcinoma | T2aN0M0 | - | II | Malignant | |
F8 | 58 | 70 | M | Bladder | Intestinal adenocarcinoma | T3aN0M0 | 2 | III | Malignant | |
F9 | 59 | 69 | M | Bladder | Adenocarcinoma | T4aN0M0 | 3 | III | Malignant | |
F10 | 60 | 68 | M | Bladder | Squamous cell carcinoma | T3aN0M0 | 2 | III | Malignant | |
G1 | 61 | 54 | M | Bladder | Normal adjacent bladder tissue | - | - | - | NAT | |
G2 | 62 | 70 | M | Bladder | Normal adjacent bladder tissue (fibrous tissue and blood vessel) | - | * | - | NAT | |
G3 | 63 | 72 | M | Bladder | Normal adjacent bladder tissue | - | - | - | NAT | |
G4 | 64 | 33 | M | Bladder | Normal adjacent bladder tissue | - | - | - | NAT | |
G5 | 65 | 58 | F | Bladder | Normal adjacent bladder tissue | - | - | - | NAT | |
G6 | 66 | 70 | M | Bladder | Cancer adjacent bladder tissue | - | - | - | AT | |
G7 | 67 | 70 | M | Bladder | Cancer adjacent bladder tissue | - | - | - | AT | |
G8 | 68 | 70 | M | Bladder | Normal adjacent bladder tissue (fibrous tissue and blood vessel) | - | * | - | NAT | |
G9 | 69 | 54 | M | Bladder | Normal adjacent bladder tissue (sparse) | - | - | - | NAT | |
G10 | 70 | 60 | M | Bladder | Normal adjacent bladder tissue | - | - | - | NAT | |
H1 | 71 | 21 | F | Bladder | Bladder tissue | - | - | - | Normal | |
H2 | 72 | 33 | M | Bladder | Bladder tissue | - | - | - | Normal | |
H3 | 73 | 21 | F | Bladder | Bladder tissue | - | - | - | Normal | |
H4 | 74 | 48 | M | Bladder | Bladder tissue | - | - | - | Normal | |
H5 | 75 | 50 | M | Bladder | Bladder tissue | - | - | - | Normal | |
H6 | 76 | 22 | M | Bladder | Bladder tissue | - | - | - | Normal | |
H7 | 77 | 45 | M | Bladder | Bladder tissue | - | - | - | Normal | |
H8 | 78 | 41 | F | Bladder | Bladder tissue (sparse) | - | - | - | Normal | |
H9 | 79 | 40 | M | Bladder | Bladder tissue | - | - | - | Normal | |
H10 | 80 | 38 | M | Bladder | Bladder tissue | - | - | - | Normal | |
- | 0 | 42 | M | Adrenal gland | Pheochromocytoma (tissue marker) | - | Malignant |
Find overlapping cases with this tissue array:
- Product Code: BL802c
- Availability: In Stock